Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 2c; Guides Above the Street

May 7, 2013 4:13 PM

Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q1 EPS of $1.37, $0.02 better than the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found